Co-Authors
This is a "connection" page, showing publications co-authored by VIVEK SUBBIAH and SIREESHA YEDURURI.
Connection Strength
0.512
-
Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience. 2023; 10:38-43.
Score: 0.231
-
Exceptional Responses to Selpercatinib in RET Fusion-Driven Metastatic Pancreatic Cancer. JCO Precis Oncol. 2023 09; 7:e2300252.
Score: 0.230
-
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition. NPJ Precis Oncol. 2021 Dec 01; 5(1):99.
Score: 0.051